| Ytd | -34.09% | |
| 1y | -46.47% |
| Open | 7.00 | Prev Close | 7.00 | Low | 6.86 | High | 7.76 | Mkt Cap | 51.19M |
| Vol | 94.51K | Avg Vol | 9.76K | EPS | -5.86 | P/E | -1.19 | Forward P/E | -0.87 |
| Beta | 1.09 | Short Ratio | 19.96 | Inst. Own | 23.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 7.29 | 200-d Avg | 10.11 | 1yr Est | 3.50 |
DRIO News
The financing was led by continued support of existing long-term institutional investors along with
DarioHealth (NASDAQ: DRIO - Get Free Report) and Echo Therapeutics (OTCMKTS:ECTE - Get Free Report)
Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further re
DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recu
This opportunity makes Dario's cardiometabolic solution available to the insurer's Administr
Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital hea
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Card
The expansion follows success with Dario's behavioral health offering. The health plan's rol
Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight
By combining Dario's multi-condition engagement offering with Beluga's physician-led, 50-sta
Dario's best-in-class, consumer-centric chronic care platform, combined now with Beluga's embedded c
DarioHealth (DRIO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the
Data from a total of 27 studies presented at ADA over 8 years reinforce Dario's strategic move close
Expansion driven by highly successful partnership based on Dario's consistent ability to engage memb
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
DarioHealth NASDAQ: DRIO reported sequential revenue growth for the second straight quarter while ou
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.81 per share versus the Zacks Consensu
First quarter 2026 revenues increased to $5.6 million, marking the second consecutive quarter of seq
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, May 4, 2026 /PRNewsw
Findings highlight the role of continuous behavioral support in improving focus, productivity and da
Mr. Palumbo's deep relationships across health systems, payers and healthcare's senior executive com
DarioHealth (NASDAQ: DRIO - Get Free Report) and Thermo Fisher Scientific (NYSE: TMO - Get Free Repo
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announc
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018